Evidence map›Paper›PMID 25538455›Full record

ArticleJournal of global infectious diseases2014

The emergence of ebola as a global health security threat: from 'lessons learned' to coordinated multilateral containment efforts.

Sarathi Kalra, Dhanashree Kelkar, Sagar C Galwankar, Thomas J Papadimos, Stanislaw P Stawicki, Bonnie Arquilla, Brian A Hoey, Richard P Sharpe, Donna Sabol, Jeffrey A Jahre

Abstract read
In one paragraph

Article in Journal of global infectious diseases, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Reconfiguring a One-Way Street: A Position Paper on Why and How to Improve Equity in Global Physician Training.Academic medicine : journal of the Association of American Medical Colleges · 2019
    Article
  14. Article
  15. Article
  16. Observational
  17. Review
  18. Key data for outbreak evaluation: building on the Ebola experience.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2017
    Review
  19. Assessments of Ebola knowledge, attitudes and practices in Forécariah, Guinea and Kambia, Sierra Leone, July-August 2015.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2017
    Article
  20. Zika Virus: An Emerging Worldwide Threat.Frontiers in microbiology · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Sarathi KalraSt Luke's University Health Network, Bethlehem, Pennsylvania, USA.
Dhanashree KelkarUniversity of Florida, Jacksonville, Florida, USA.
Sagar C GalwankarUniversity of Florida, Jacksonville, Florida, USA.
Thomas J PapadimosThe Ohio State University College of Medicine, Columbus, Ohio, USA.
Stanislaw P StawickiSt Luke's University Health Network, Bethlehem, Pennsylvania, USA.
Bonnie ArquillaSUNY Downstate Medical Center, Brooklyn, New York, USA.
Brian A HoeySt Luke's University Health Network, Bethlehem, Pennsylvania, USA.
Richard P SharpeSt Luke's University Health Network, Bethlehem, Pennsylvania, USA.
Donna SabolSt Luke's University Health Network, Bethlehem, Pennsylvania, USA.
Jeffrey A JahreSt Luke's University Health Network, Bethlehem, Pennsylvania, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

First reported in remote villages of Africa in the 1970s, the Ebolavirus was originally believed to be transmitted to people from wild animals. Ebolavirus (EBOV) causes a severe, frequently fatal hemorrhagic syndrome in humans. Each outbreak of the Ebolavirus over the last three decades has perpetuated fear and economic turmoil among the local and regional populations in Africa. Until now it has been considered a tragic malady confined largely to the isolated regions of the African continent, but it is no longer so. The frequency of outbreaks has increased since the 1970s. The 2014 Ebola outbreak in Western Africa has been the most severe in history and was declared a public health emergency by the World Health Organization. Given the widespread use of modern transportation and global travel, the EBOV is now a risk to the entire Global Village, with intercontinental transmission only an airplane flight away. Clinically, symptoms typically appear after an incubation period of approximately 11 days. A flu-like syndrome can progress to full hemorrhagic fever with multiorgan failure, and frequently, death. Diagnosis is confirmed by detection of viral antigens or Ribonucleic acid (RNA) in the blood or other body fluids. Although historically the mortality of this infection exceeded 80%, modern medicine and public health measures have been able to lower this figure and reduce the impact of EBOV on individuals and communities. The treatment involves early, aggressive supportive care with rehydration. Core interventions, including contact tracing, preventive initiatives, active surveillance, effective isolation and quarantine procedures, and timely response to patients, are essential for a successful outbreak control. These measures, combined with public health education, point-of-care diagnostics, promising new vaccine and pharmaceutical efforts, and coordinated efforts of the international community, give new hope to the Global effort to eliminate Ebola as a public health threat. Here we present a review of EBOV infection in an effort to further educate medical and political communities on what the Ebolavirus disease entails, and what efforts are recommended to treat, isolate, and eventually eliminate it.

Indexed as

ContainmentEbolavirusEpidemicGlobal Health Security AgendaGlobal responseGovernment response systemOutbreakVirus transmission

Identifiers

PMID25538455
PMCPMC4265832

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.